Equities

Advanced Medical Solutions Group PLC

AMS:LSE

Advanced Medical Solutions Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)194.20
  • Today's Change4.80 / 2.53%
  • Shares traded442.66k
  • 1 Year change-20.73%
  • Beta0.6848
Data delayed at least 20 minutes, as of May 01 2024 16:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Advanced Medical Solutions Group plc is a United Kingdom-based developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. The Company offers a range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, bone substitutes and internal sealants, which it markets under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIXTM and SEAL-G brands. The Company also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal brand as well as under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit is comprised of multi-product portfolio of advanced wound care dressings and a portfolio of specialist medical bulk materials and multi-layer wound care products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, the Czech Republic and Israel.

  • Revenue in GBP (TTM)126.21m
  • Net income in GBP15.89m
  • Incorporated1993
  • Employees800.00
  • Location
    Advanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
  • Phone+44 16 0686 3500Fax+44 16 0686 3600
  • Websitehttps://www.admedsol.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Tristel Plc39.49m6.04m220.99m213.00220.99m213.00
Nyxoah SA3.72m-36.95m229.56m147.00229.56m147.00
BICO Group AB164.34m-123.94m233.61m884.00233.61m884.00
Lumibird SA174.05m6.09m239.16m1.05k239.16m1.05k
Medistim ASA38.38m7.41m240.61m152.00240.61m152.00
COLTENE Holding AG211.63m10.42m267.79m1.20k267.79m1.20k
IVF Hartmann Holding AG129.00m13.21m290.85m304.00290.85m304.00
Ion Beam Applications SA366.57m-7.79m325.73m1.99k325.73m1.99k
Avon Protection PLC195.20m-13.13m363.95m928.00363.95m928.00
CellaVision AB51.74m10.32m392.87m223.00392.87m223.00
Advanced Medical Solutions Group plc126.21m15.89m411.64m800.00411.64m800.00
Safilo Group SpA876.18m-21.08m412.52m3.83k412.52m3.83k
Stratec SE215.73m10.38m450.12m1.47k450.12m1.47k
medmix AG424.25m261.56k543.23m2.66k543.23m2.66k
Synsam AB (publ)431.33m22.72m562.08m3.41k562.08m3.41k
Revenio Group Oyj82.66m16.25m597.71m216.00597.71m216.00
Data as of May 01 2024. Currency figures normalised to Advanced Medical Solutions Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

47.50%Per cent of shares held by top holders
HolderShares% Held
Octopus Investments Ltd.as of 24 Apr 202428.31m13.03%
Canaccord Genuity Wealth Ltd.as of 29 Dec 202316.60m7.64%
Investec Wealth & Investment Ltd.as of 29 Dec 202312.69m5.84%
Charles Stanley & Co. Ltd.as of 29 Dec 202311.32m5.21%
Invesco Asset Management Ltd.as of 29 Dec 20238.57m3.94%
Rathbones Investment Management Ltd.as of 21 Sep 20237.17m3.30%
AXA Investment Managers UK Ltd.as of 29 Dec 20236.85m3.15%
Evelyn Partners Investment Management LLPas of 01 Feb 20244.02m1.85%
BlackRock Fund Advisorsas of 01 Feb 20243.94m1.81%
Royal London Asset Management Ltd.as of 01 Feb 20243.78m1.74%
More ▼
Data from 31 Dec 2023 - 29 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.